KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Depreciation & Amortization (CF) (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Depreciation & Amortization (CF) for 13 consecutive years, with -$7000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 103.03% to -$7000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $814000.0 through Dec 2025, down 11.81% year-over-year, with the annual reading at $814000.0 for FY2025, 11.81% down from the prior year.
  • Depreciation & Amortization (CF) hit -$7000.0 in Q4 2025 for ClearPoint Neuro, down from $360000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $420000.0 in Q4 2021 to a low of -$7000.0 in Q4 2025.
  • Historically, Depreciation & Amortization (CF) has averaged $171450.0 across 5 years, with a median of $198000.0 in 2022.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 687.5% in 2021 and later crashed 103.03% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $420000.0 in 2021, then plummeted by 68.33% to $133000.0 in 2022, then plummeted by 72.93% to $36000.0 in 2023, then soared by 541.67% to $231000.0 in 2024, then plummeted by 103.03% to -$7000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for CLPT at -$7000.0 in Q4 2025, $360000.0 in Q3 2025, and $230000.0 in Q2 2025.